Skip to Main Content

Paper Details

An EGFR targeted PET imaging probe for the detection of colonic adenocarcinomas in the setting of colitis.
Theranostics
29
2014
(18)F FDG, (18)F-FDG, (64)Cu, (67)Ga, CT26 cells, CT26 tumor, CT26 tumors, Cetuximab F(ab')2 fragments, Colorectal cancer, DOTA, EGFR, F(ab')2, FDG, GEM models, adenomas, cetuximab, colitis, colon cancer, colonic adenocarcinomas, colonic lesions, colonic tumors, inflammatory bowel disease, mice, mouse, neoplastic lesion, patients, sodium sulfate
Author NameAffiliation
Pedram Heidari1. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School
Raju KucherlapatiBrigham and Women's Hospital, Harvard Medical School
Raju KucherlapatiBrigham and Women's Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2